Serum markers in testicular tumors

Area of Science:

• Oncology
• Biochemistry

Background:

• Cancer biomarkers play a crucial role in the diagnosis and management of various cancers.
• Serum tumor markers, such as alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (beta-hCG), are increasingly utilized in clinical practice.

Purpose of the Study:

• To evaluate the utility of serum AFP and beta-hCG estimation in patients diagnosed with testicular tumors.
• To explore potential correlations between tumor histology and serum marker levels in testicular cancer.

Main Methods:

• Serum levels of alpha-fetoprotein and beta-human chorionic gonadotropin were measured in patients with testicular tumors.
• Histopathological analysis of testicular tumor samples was performed.
• Correlation analysis between marker levels, tumor histology, and clinical presentation was conducted.

Main Results:

• Elevated serum markers were observed in 17 patients with germ cell testicular tumors.
• Three patients with seminoma of the testis all exhibited elevated beta-human chorionic gonadotropin levels.
• No definitive correlation was found between the specific histology of testicular tumors and the type of elevated serum markers.
• All patients with elevated markers had active tumors, but three patients with metastatic disease in para-aortic lymph nodes did not show elevated markers.

Conclusions:

• Serum AFP and beta-hCG are valuable tools in the management of testicular tumors.
• While certain markers may be associated with specific tumor types (e.g., beta-hCG in seminoma), a direct histological correlation is not consistently possible.
• The absence of elevated markers in some metastatic cases highlights the need for comprehensive diagnostic approaches.